Clinical Trials Directory

Trials / Completed

CompletedNCT03750591

Observational Study on Effectiveness and Safety of Integrative Korean Medicine Treatment for Inpatients With Sciatica Due to Lumbar Intervertebral Disc Herniation

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Jaseng Medical Foundation · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Observational study on the effectiveness and safety of integrative Korean medicine treatment for inpatients with sciatica due to lumbar intervertebral disc herniation

Detailed description

Establishment of a Korean medicine inpatient treatment registry of inpatients with sciatica due to lumbar intervertebral disc herniation with or without spinal stenosis, in conjunction with an observational study to the aim of evaluating the effectiveness and safety of Korean medicine treatment for inpatients

Conditions

Interventions

TypeNameDescription
DRUGHerbal medicineHerbal medicine will be mainly administered in water-based decoction (120ml) and dried powder (2g) form (the ingredients are mainly, but not restricted to: Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, Saposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycine max, Atractylodes japonica).
PROCEDUREChuna manual therapyChuna is a Korean spinal manipulation that incorporates spinal manipulation techniques for joint mobilization involving highvelocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manipulation will be administered at the physician's discretion.
PROCEDUREBee venom pharmacopunctureBee venom pharmacopuncture will be administered only after confirming a negative response to hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) filtered for allergens will be injected at 4-5 acupoints proximal to the dysfunctional site at the physician's discretion. Each acupuncture point will be injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26gauze(G) x 1.5 syringe, Shinchang medical co., Korea).
PROCEDUREPharmacopuncturePharmacopuncture consisting of select herbal ingredients will be administered at Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26gauze(G) x 1.5 syringe, Shinchang medical co., Korea).
PROCEDUREAcupunctureAcupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
PROCEDUREElectroacupunctureElectroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
PROCEDURECuppingCupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.
OTHEROther intervention(s)Patients will be allowed any other additional intervention(s) as deemed necessary by the attending physician regardless of type or dose, and patterns of use will be investigated and recorded as an pragmatic clinical study.

Timeline

Start date
2018-03-31
Primary completion
2019-05-10
Completion
2019-11-08
First posted
2018-11-23
Last updated
2020-03-13

Locations

4 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03750591. Inclusion in this directory is not an endorsement.

Observational Study on Effectiveness and Safety of Integrative Korean Medicine Treatment for Inpatients With Sciatica Du (NCT03750591) · Clinical Trials Directory